Cargando…

Influence of HLA Class II Polymorphism on Predicted Cellular Immunity Against SARS-CoV-2 at the Population and Individual Level

Development of adaptive immunity after COVID-19 and after vaccination against SARS-CoV-2 is predicated on recognition of viral peptides, presented on HLA class II molecules, by CD4+ T-cells. We capitalised on extensive high-resolution HLA data on twenty five human race/ethnic populations to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Copley, Hannah C., Gragert, Loren, Leach, Andrew R., Kosmoliaptsis, Vasilis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327207/ https://www.ncbi.nlm.nih.gov/pubmed/34349756 http://dx.doi.org/10.3389/fimmu.2021.669357

Ejemplares similares

Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
por: Kim, Jon Jin, et al.
Publicado: (2023)

Corrigendum: Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation
por: Kim, Jon Jin, et al.
Publicado: (2023)

HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes
por: Alter, Idan, et al.
Publicado: (2017)

Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern
por: López, Daniel
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

Assessment of human leukocyte antigen immunogenicity: current methods, challenges and opportunities
por: Copley, Hannah C., et al.
Publicado: (2018)

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
por: Weidner, Lisa, et al.
Publicado: (2021)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

HLA Class I or Class II and Disease Association: Catch the Difference If You Can
por: Fiorillo, Maria Teresa, et al.
Publicado: (2017)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
por: Wendorff, Mareike, et al.
Publicado: (2020)

Comprehensive Analysis of CD4(+) T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II
por: Hyun, You-Seok, et al.
Publicado: (2022)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine
por: Yao, Yufeng, et al.
Publicado: (2019)

Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance
por: Denzin, Lisa K.
Publicado: (2013)

HLA genetic polymorphism in patients with Coronavirus Disease 2019 in Midwestern United States
por: Schindler, Emily, et al.
Publicado: (2021)

A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity
por: Wiebe, Chris, et al.
Publicado: (2018)

Comprehensive analysis of mycobacterium tuberculosis antigen-specific CD4(+) T cell responses restricted by single HLA class II allotype in an individual
por: Lee, Yong-Hun, et al.
Publicado: (2022)

Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia
por: Klitz, William, et al.
Publicado: (2012)

Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond
por: Pagliuca, Simona, et al.
Publicado: (2022)

Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer
por: Tsai, Ya-Yu, et al.
Publicado: (2023)

Measuring Ambiguity in HLA Typing Methods
por: Paunić, Vanja, et al.
Publicado: (2012)

Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential
por: Mallon, Dermot H., et al.
Publicado: (2018)

A template for multitudes: Germline immune polymorphism of the T cell receptor loci
por: Gragert, Loren
Publicado: (2022)

HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022)

MHC Class II Polymorphisms, Autoreactive T-Cells, and Autoimmunity
por: Tsai, Sue, et al.
Publicado: (2013)

HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy
por: Couture, Alexandre, et al.
Publicado: (2019)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
por: Lakoš Jukić, Ines, et al.
Publicado: (2023)

HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-19 Severity
por: Hovhannisyan, Anahit, et al.
Publicado: (2022)

Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut
por: Berryman, Meghan A., et al.
Publicado: (2023)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Editorial: Future challenges and directions in determining allo-immunity in kidney transplantation
por: Lim, Wai H., et al.
Publicado: (2022)

Targeting KRAS(G12V) mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors
por: Ai, Qi, et al.
Publicado: (2023)

Perspective of HLA-G Induced Immunosuppression in SARS-CoV-2 Infection
por: Lin, Aifen, et al.
Publicado: (2021)

Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease
por: Xu, Alexander M., et al.
Publicado: (2022)

SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
por: Dada, Ashraf, et al.
Publicado: (2022)

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
por: Yang, Junbao, et al.
Publicado: (2009)

Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population
por: Kawasaki, Aya, et al.
Publicado: (2023)

Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms
por: Saulle, Irma, et al.
Publicado: (2021)

HLA and Non-HLA gene polymorphisms in autoimmune hepatitis patients of North Indian adults
por: Ahuja, Nishtha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96n91826cg8br70436fgv622pg